Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target
Roger S. Smith, Barbara H. Iglewski
Roger S. Smith, Barbara H. Iglewski
Published November 15, 2003
Citation Information: J Clin Invest. 2003;112(10):1460-1465. https://doi.org/10.1172/JCI20364.
View: Text | PDF
Perspective Series

Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target

  • Text
  • PDF
Abstract

Pseudomonas aeruginosa has two complete quorum-sensing systems. Both of these systems have been shown to be important for Pseudomonas virulence in multiple models of infection. Thus, these systems provide unique targets for novel antimicrobial drugs.

Authors

Roger S. Smith, Barbara H. Iglewski

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Potential QS targets for the inhibition of P. aeruginosa virulence. For ...
Potential QS targets for the inhibition of P. aeruginosa virulence. For simplicity, only the las QS system is shown; however, similar mechanisms could be used to inhibit the rhl system as well. (a) P. aeruginosa LasI synthase utilizes S-adenosyl methionine (SAM) and acyl-ACP to form 3O-C12-HSL. As the density of the bacteria, and thus of 3O-C12-HSL, increases, the 3O-C12-HSL molecule binds to the LasR regulator, resulting in dimerization, DNA binding, and transcription of multiple genes. (b) Antagonistic analogues of cognate AHLs compete for binding to LasR but do not result in activation of the protein. (c) Specific antibodies bind to AHLs as they exit the bacteria, inhibiting their re-entry and thus inhibiting activation of LasR as well as their interaction with host cells. (d) Lactonases degrade AHLs as they leave the bacteria, thus inhibiting their activation of LasR and host cells. (e) Targeting the expression of LasI substrates would prevent the production of 3O-C12-HSL, and thus QS activation. (f) Multiple factors have been shown to regulate lasR and lasI. Drugs that inhibit these factors would result in altered QS activation. (g) Specific antisense oligonucleotides (oligos) pair with lasR or lasI RNA and inhibit gene translation and thus protein production.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts